Literature DB >> 31198957

Testing clonal relatedness of two tumors from the same patient based on their mutational profiles: update of the Clonality R package.

Audrey Mauguen1, Venkatraman E Seshan1, Colin B Begg1, Irina Ostrovnaya1.   

Abstract

SUMMARY: The Clonality R package is a practical tool to assess the clonal relatedness of two tumors from the same patient. We have previously presented its functionality for testing tumors using loss of heterozygosity data or copy number arrays. Since then somatic mutation data have been more widely available through next generation sequencing and we have developed new methodology for comparing the tumors' mutational profiles. We thus extended the package to include these two new methods for comparing tumors as well as the mutational frequency estimation from external data required for their implementation. The first method is a likelihood ratio test that is readily available on a patient by patient basis. The second method employs a random-effects model to estimate both the population and individual probabilities of clonal relatedness from a group of patients with pairs of tumors. The package is available on Bioconductor.
AVAILABILITY AND IMPLEMENTATION: Bioconductor (http://bioconductor.org/packages/release/bioc/html/Clonality.html). SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2019        PMID: 31198957      PMCID: PMC6853680          DOI: 10.1093/bioinformatics/btz486

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  5 in total

1.  Estimating the probability of clonal relatedness of pairs of tumors in cancer patients.

Authors:  Audrey Mauguen; Venkatraman E Seshan; Irina Ostrovnaya; Colin B Begg
Journal:  Biometrics       Date:  2017-05-08       Impact factor: 2.571

2.  Clonality: an R package for testing clonal relatedness of two tumors from the same patient based on their genomic profiles.

Authors:  Irina Ostrovnaya; Venkatraman E Seshan; Adam B Olshen; Colin B Begg
Journal:  Bioinformatics       Date:  2011-05-05       Impact factor: 6.937

3.  USING SOMATIC MUTATION DATA TO TEST TUMORS FOR CLONAL RELATEDNESS.

Authors:  Irina Ostrovnaya; Venkatraman E Seshan; Colin B Begg
Journal:  Ann Appl Stat       Date:  2015-11-02       Impact factor: 2.083

4.  Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.

Authors:  Kyle Ellrott; Matthew H Bailey; Gordon Saksena; Kyle R Covington; Cyriac Kandoth; Chip Stewart; Julian Hess; Singer Ma; Kami E Chiotti; Michael McLellan; Heidi J Sofia; Carolyn Hutter; Gad Getz; David Wheeler; Li Ding
Journal:  Cell Syst       Date:  2018-03-28       Impact factor: 10.304

5.  Clonal relationships between lobular carcinoma in situ and other breast malignancies.

Authors:  Colin B Begg; Irina Ostrovnaya; Jose V Scarpa Carniello; Rita A Sakr; Dilip Giri; Russell Towers; Michail Schizas; Marina De Brot; Victor P Andrade; Audrey Mauguen; Venkatraman E Seshan; Tari A King
Journal:  Breast Cancer Res       Date:  2016-06-23       Impact factor: 6.466

  5 in total
  2 in total

1.  The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.

Authors:  Thomas van Doeveren; Jose A Nakauma-Gonzalez; Andrew S Mason; Geert J L H van Leenders; Tahlita C M Zuiverloon; Ellen C Zwarthoff; Isabelle C Meijssen; Angelique C van der Made; Antoine G van der Heijden; Kees Hendricksen; Bas W G van Rhijn; Charlotte S Voskuilen; Job van Riet; Winand N M Dinjens; Hendrikus J Dubbink; Harmen J G van de Werken; Joost L Boormans
Journal:  Int J Cancer       Date:  2020-10-13       Impact factor: 7.396

Review 2.  Evaluating statistical approaches to define clonal origin of tumours using bulk DNA sequencing: context is everything.

Authors:  Tanjina Kader; Magnus Zethoven; Kylie L Gorringe
Journal:  Genome Biol       Date:  2022-02-02       Impact factor: 13.583

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.